Hemmati F, Pishva N
Pediatric Department, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Singapore Med J. 2009 Sep;50(9):875-8.
Previous studies report the spectrum of thyroid function abnormalities in critically-ill neonates. In this study, we evaluated the thyroid status in critically-ill neonates, and determined whether thyroid function abnormalities are more common in sick neonatal infants.
In a prospective cohort study, 67 critically-ill infants from the Neonatal Intensive Care Unit (NICU), affiliated to Shiraz University of Medical Sciences, were entered into our study. Of all the included neonates, 33 were premature and seven were under 28 weeks of gestation. In addition to the routine thyroid-stimulating hormone (TSH)-screening (capillary specimen), serum free triiodothyronine (FT3), free thyroxine (FT4) and TSH were checked using radioimmunoassay kit twice (during critical illness and before discharge from the NICU).
It was observed that abnormal TSH levels (screening test) were about 40-fold higher in critically-ill neonates compared with healthy neonates, while more than four-fifths of them were detected in the second sampling done after recovery. The mean FT3 was significantly lower during the critical illness and it increased after recovery (2.537 and 3.232 pg/ml, respectively). Mean FT4 and mean TSH during the illness and after recovery did not have any significant difference.
Thyroid function abnormalities are more common in infants under intensive care and most of them manifested as "euthyroid sick syndrome"; abnormal screening tests may be due to the transient elevation of TSH during recovery from illness. Therefore, only in cases in which TSH rises more than 15-20 mIU/L or TSH remains high for a month or longer, that treatment is needed, while other cases must be followed up by serial determination of TSH and FT4. The levels of FT3 and FT4 during the illness were not affected by the duration and severity of the illness.
既往研究报道了危重新生儿甲状腺功能异常的情况。在本研究中,我们评估了危重新生儿的甲状腺状态,并确定甲状腺功能异常在患病新生儿中是否更常见。
在一项前瞻性队列研究中,来自设拉子医科大学附属新生儿重症监护病房(NICU)的67例危重新生儿纳入我们的研究。所有纳入的新生儿中,33例为早产儿,7例妊娠不足28周。除常规甲状腺刺激激素(TSH)筛查(末梢血标本)外,使用放射免疫分析试剂盒在危重病期间和NICU出院前两次检测血清游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)和TSH。
观察到危重新生儿异常TSH水平(筛查试验)比健康新生儿高约40倍,其中超过五分之四在恢复后第二次采样时检测到。危重病期间平均FT3显著降低,恢复后升高(分别为2.537和3.232 pg/ml)。疾病期间和恢复后的平均FT4和平均TSH无显著差异。
甲状腺功能异常在重症监护的婴儿中更常见,且大多数表现为“正常甲状腺病态综合征”;筛查试验异常可能是由于疾病恢复过程中TSH短暂升高所致。因此,仅在TSH升高超过15 - 20 mIU/L或TSH持续高水平达1个月或更长时间的情况下才需要治疗,而其他情况必须通过连续测定TSH和FT4进行随访。疾病期间FT3和FT4水平不受疾病持续时间和严重程度的影响。